Opinion|Videos|May 23, 2024
Tailoring Treatment: Patient Factors Guiding First-Line Medication Selection for Older Adults with Type 2 Diabetes
Drs Medha Munshi and James Bailey offer insights into navigating the type 2 diabetes treatment landscape. They emphasize the importance of prioritizing cardiovascular and renal outcomes when selecting treatments for older adult populations.
Advertisement
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
Advertisement
Advertisement
Trending on Patient Care Online
1
When Night Sweats Signal Something Other Than Menopause
2
New Schizophrenia Treatment Addresses Long-Standing LAI Barriers
3
Abbott's Amulet 360 Linked to Low Stroke Risk at 1 Year in Late-Breaking Research
4
4 FDA Decisions for Primary Care to Know from October 2026
5